Daxor Announces Acquisition of BVA-100 Blood Volume Analyzer to Aspirus Wausau Hospital in Wisconsin

Daxor (NYSE:DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement, today announces that Aspirus Wausau Hospital in Wausau Wisconsin has acquired a BVA-100 Blood Volume Analyzer.

As quoted in the press release:

Best known for its world-class cardiovascular program, Aspirus Wausau Hospital also provides leading edge cancer, trauma, women’s health, and spine and neurological care. Aspirus Wausau Hospital is the flagship of the Aspirus system that serves patients in 14 counties across northern and central Wisconsin, as well as the Upper Peninsula of Michigan. It is licensed for 325 beds and staffed by 350 physicians in 35 specialties.

The hospital is continually recognized nationally for the level of care it provides. Aspirus Wausau Hospital has earned high quality ratings or awards from prominent quality agencies such as HealthGrades, Thomson Reuters, Truven Health, Becker’s Hospital Review, Mission: Lifeline^® and U.S. News & World Report.

“We look forward to partnering with Aspirus Hospital to integrate blood volume analysis as standard of care by providing clinicians with rapid, accurate and actionable information to inform better treatment strategies not only in heart failure, but in a wide variety of surgical and medical conditions,” said Michael Feldschuh, CEO of Daxor Corporation. “Objective measurement of volume status and composition enables individualization of treatment to ensure better outcomes for patients and better quality of life.”

Click here to read the full press release.